Hydrochloric Acid

Hydrochloric Acid

SCHEMBL4427673

CC[Al+2].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[Cl-].[W+4]

nearest known ligand 0.31

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 3)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.31
PMP22 Q01453 1/20 0.31
ATM Q13315 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL27596871 0.94 KDM4E (0.33) KDM4EPMP22ATM
Hydrochloric Acid SCHEMBL42633 0.94
Hydrochloric Acid SCHEMBL29138657 0.88
Hydrochloric Acid SCHEMBL6112720 0.88
Hydrochloric Acid SCHEMBL11293783 0.88
Hydrochloric Acid SCHEMBL8373829 0.88 KDM4E (0.31) KDM4EPMP22ATM
Hydrochloric Acid SCHEMBL28428088 0.88
Hydrochloric Acid SCHEMBL11818575 0.88 KDM4E (0.31) KDM4EPMP22ATM
Water SCHEMBL11418110 0.88
Hydrochloric Acid SCHEMBL27912453 0.88

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024097531-A1 TANDEM ALKANE METATHESIS AND CATALYZED DEPOLYMERIZATION FOR CHEMICALLY COMPLEX CIRCULAR FEEDSTOCK CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2024-05-10 WO claimed
US-20240141130-A1 TANDEM ALKANE METATHESIS AND CATALYZED DEPOLYMERIZATION FOR CHEMICALLY COMPLEX CIRCULAR FEEDSTOCK CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2024-05-02 US claimed
EP-4399195-A1 SELECTIVE 1-HEXENE/1-OCTENE PRODUCTION WITH 1-DECENE Chevron Phillips Chemical Company LP (US) 2024-07-17 EP disclosed
WO-2024097531-A1 TANDEM ALKANE METATHESIS AND CATALYZED DEPOLYMERIZATION FOR CHEMICALLY COMPLEX CIRCULAR FEEDSTOCK CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2024-05-10 WO disclosed
US-20240141130-A1 TANDEM ALKANE METATHESIS AND CATALYZED DEPOLYMERIZATION FOR CHEMICALLY COMPLEX CIRCULAR FEEDSTOCK CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2024-05-02 US disclosed
CN-117916214-A Selective production of 1-hexene/1-octene with 1-decene 切弗朗菲利浦化学公司 2024-04-19 CN disclosed
WO-2024076862-A1 OLEFIN METATHESIS IN A LOOP REACTOR CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2024-04-11 WO disclosed
WO-2024044566-A1 OLEFIN METATHESIS BY REACTIVE DISTILLATION CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2024-02-29 WO disclosed
US-11820740-B1 Olefin metathesis by reactive distillation CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2023-11-21 US disclosed
US-11746071-B1 Olefin metathesis in a loop reactor CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2023-09-05 US disclosed
US-20230101033-A1 SELECTIVE 1-HEXENE/1-OCTENE PRODUCTION WITH 1-DECENE CHEVRON PHILLIPS CHEMICAL COMPANY LP 2023-03-30 US disclosed
US-10183899-B2 Normal alpha olefin synthesis using metathesis and dehydroformylation CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2019-01-22 US disclosed
WO-2018226408-A2 METHOD OF INCREASING ALPHA-OLEFIN CONTENT LIQUIDPOWER SPECIALTY PRODUCTS, INC. (US) 2018-12-13 WO disclosed
US-20180346830-A1 METHOD OF INCREASING ALPHA-OLEFIN CONTENT LIQUIDPOWER SPECIALTY PRODUCTS INC. 2018-12-06 US disclosed
US-20180127329-A1 Normal Alpha Olefin Synthesis Using Metathesis and Dehydroformylation CHEVRON PHILLIPS CHEMICAL COMPANY LP 2018-05-10 US disclosed
US-8765984-B2 Methods and systems for making thiol compounds from terminal olefinic compounds CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2014-07-01 US disclosed
US-20120232297-A1 Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2012-09-13 US disclosed
WO-2009132010-A1 METHODS AND SYSTEMS FOR MAKING THIOL COMPOUNDS FROM TERMINAL OLEFINIC COMPOUNDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2009-10-29 WO disclosed
US-20090264669-A1 Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2009-10-22 US disclosed
US-20090043140-A1 Narrow cut waxes and method of making CHEVRON PHILLIPS CHEMICAL COMPANY LP 2009-02-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180127329-A1 Normal Alpha Olefin Synthesis Using Metathesis and Dehydroformylation DHPS, CYP8B1, FDFT1 KDM4E 4366/4885PMP22 3067/4885ATM 2952/4885
US-20230101033-A1 SELECTIVE 1-HEXENE/1-OCTENE PRODUCTION WITH 1-DECENE OXER1, CYP8B1, DHPS KDM4E 4287/4885PMP22 3608/4885ATM 2639/4885
US-20120232297-A1 Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds TST, HHAT, GSTO1 KDM4E 2861/4885PMP22 4217/4885ATM 1501/4885
US-10183899-B2 Normal alpha olefin synthesis using metathesis and dehydroformylation DHPS, CYP8B1, FDFT1 KDM4E 4366/4885PMP22 3067/4885ATM 2952/4885
US-20090264669-A1 Methods and Systems for Making Thiol Compounds from Terminal Olefinic Compounds TST, HHAT, GSTO1 KDM4E 2861/4885PMP22 4217/4885ATM 1501/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.